Company Summary
Search
Home Page
 
Waverley Pharma Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
December 31TradingN
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
14/Dec/2016  Canada   
Exchange Filing Office
Location
Calgary Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Pharmaceuticals & Cosmetics  (not available) 
Securities
SymbolSecurity NameMarketStatus
WAVEWaverley Pharma Inc.TSX VentureTRADING
Name HistoryFromTo
Waverley Pharma Inc.27/Oct/2017Present
Company Facts Reconciliation
SubjectDate Returned
(not available)
Associations
Auditing Firm:  MNP LLP
Sponsor:  PI Financial Corp.
Transfer Agent:  Computershare Investor Services Inc.
Latest Information
TypeDateTitle
News Releases  27/May/2021  NEWS RELEASE - WAVERLEY PHARMA ANNOUNCES SUCCESSFUL TENDER AWARD FOR PEMETREXED WITH NHS ENGLAND[CANADA NEWSWIRE]
    NEWS RELEASE - WAVERLEY PHARMA ANNOUNCES SUCCESSFUL TENDER AWARD FOR CAPECITABINE WITH NHS SCOTLAND[CANADA NEWSWIRE]
    NEWS RELEASE - WAVERLEY PHARMA ANNOUNCES TENTATIVE ANDA APPROVAL FOR PEMETREXED IN THE UNITED STATES[CANADA NEWSWIRE]
Bulletins  16/Aug/2021  Shares for Bonuses
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data